CAS 1021869-29-3

methyl 2-(1H-1,2,3-triazol-1-yl)acetate

Codes: MOLID-003

Application context (from source-drug indications)

Chronic renal impairmentMolidustat SodiumAnaemiaMolidustat SodiumKidney diseaseMolidustat Sodium

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Molidustat Sodium	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Molidustat SodiumProcess routesteps: 5total yield: 57.4 kg

1H-1,2,3-triazole→methyl 2-bromoacetate→methyl 2-(1H-1,2,3-triazol-1-yl)acetate→methyl (E)-3-(dimethylamino)-2-(1H-1,2,3-triazol-1-yl)acrylate→4-(6-hydrazinylpyrimidin-4-yl)morpholine→4,6-dichloropyrimidine→4-chloro-6-hydrazinylpyrimidine→morpholine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.